Stanford University
Showing 81-100 of 206 Results
-
Neil Kamdar
Assistant Director of Analytics, Center for Population Health Sciences
Biostatistician 3, Center for Population Health SciencesBioI am a health services researcher and applied methodologist focused on clinical and policy applications in disabilities research, women's health, general surgery, and mental health analyses. My focus has been on leveraging Medicare, private payer claims (Health Care Cost Institute (HCCI), MarketScan, OptumInsight, etc.) and Medicaid to understand cost, utilization, and outcomes. This work has been foundational in the development of large-scale studies on vulnerable populations that have typically been under-served or insufficiently studies in the health services research domain.
I serve as the Assistant Director of Analytics at the Center for Population Health Sciences at Stanford, focused on the development of the American Family Cohort (AFC) data, a primary care registry that provides substantial insights into clinical outcomes, utilization, and a particular focus on COVID-19 and Long COVID outcome analyses. Ancillary work would involve the development of research collaborations throughout Stanford Medicine with the interest in creating scholarship across the many domains of the Center for Population Health Sciences.
In addition to this role at Stanford, I also maintain an appointment at the University of Michigan, Institute for Healthcare Policy and Innovation, where I serve as an analytic lead in the development of administrative claims and electronic medical records analyses leading to publications in general and subject-specific journals.
I have been successful in being funded as a co-investigator with several federal and foundation agencies, including the National Institutes of Health (NIH), Department of Defense (DOD), Agency for Healthcare Research and Quality (AHRQ), Neilsen Foundation focused on traumatic spinal cord injury, among many others. I have also provided foundational analyses in the development of Clinical Quality Initiatives (CQIs), which are state-wide initiatives aimed at improving the health and efficiency of hospitals and institutions, with a focus on maternal and fetal medicine in the State of Michigan. -
Ankita Kaulberg
Head of Product, Our Voice Platform, Epidemiology and Population Health
Current Role at StanfordHead of Product, Our Voice Platform
Stanford School of Medicine -
Mathew Kiang
Assistant Professor of Epidemiology and Population Health (Epidemiology)
BioI am an assistant professor in the Department of Epidemiology and Population Health. My research lies at the intersection of computational epidemiology and social epidemiology. Methodologically, my work revolves around combining disparate data sources in epidemiologically meaningful ways. For example, I work with individual-level, non-health data (e.g., GPS, accelerometer, and other sensor data from smartphones), traditional health data (e.g., survey, health systems, or death certificate data), and third-party data (e.g., cellphone providers or ad-tech data). To do this, I use a variety of methods such as joint Bayesian spatial models, traditional epidemiologic models, dynamical models, microsimulation, and demographic analysis. Substantively, my work focuses on socioeconomic and racial/ethnic inequities. For example, recently, my work has examined inequities in COVID-19 vaccine distribution, cause-specific excess mortality, and drug poisonings. I have an NIDA-funded R00 examining equitable ways to improve treatment for opioid use disorder across structurally disadvantaged groups and am Co-I on a NIDA-funded R21 examining ways to use novel data sources (such as social media) to predict surges in opioid-related mortality.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
Eric Koenig Gonzalez
Casual - Non-Exempt, Epidemiology and Population Health
BioEric is an undergraduate Computer Engineering student currently interning at the Epidemiology and Population Health Department. Currently working on developing the back end of the systems used for the Food for Health Equity Lab.
-
Allison W. Kurian, M.D., M.Sc.
Professor of Medicine (Oncology) and of Epidemiology and Population Health
Current Research and Scholarly InterestsI aim to understand cancer burden and improve treatment quality at the population level. I have a strong focus on genetic risk assessment and precision oncology. I lead epidemiologic studies of cancer risk factors, clinical trials of novel approaches to cancer risk reduction, and decision analyses of strategies to optimize cancer outcomes.
-
Lianne Kurina
Professor (Teaching) of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy research focuses on the physical and mental health of military service members.
-
Angelle Desiree LaBeaud
Professor of Pediatrics (Infectious Diseases), Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Epidemiology and Population Health and at the Stanford Doerr School of Sustainability
Current Research and Scholarly InterestsArthropod-borne viruses are emerging and re-emerging infections that are spreading throughout the world. Our laboratory investigates the epidemiology of arboviral infections, focusing on the burden of disease and the long-term complications on human health. In particular, Dr. LaBeaud investigates dengue, chikungunya, and Rift Valley fever viruses in Kenya, where outbreaks cause fever, arthritis, retinitis, encephalitis, and hemorrhagic fever. Our main research questions focus on the risk factors for arboviral infections, the development of diagnostic tests that can be administered in the field to quickly determine what kind of arboviral infection a person has, and the genetic and immunologic investigation of why different people respond differently to the same infection. Our long-term goals are to contribute to a deeper understanding of arboviral infections and their long-term health consequences and to optimize control strategies to prevent these emerging infections. Our laboratory also investigates the effects of antenatal and postnatal parasitic infections on vaccine responses, growth, and development of Kenyan children.
My lab at Stanford supports the field work that is ongoing in Kenya, but we also have several projects that are based locally. We strive to improve diagnostics of arboviral infections and are using Luminex technology to build a new screening assay. We also have created a Luminex based platform to assess vaccine responses against multiple pathogens. -
Tracy Lam-Hine
Postdoctoral Scholar, Epidemiology
BioTracy Lam-Hine (he/him), DrPH, MBA, is a postdoctoral research fellow mentored by Dr. David Rehkopf in the Stanford Medicine Department of Epidemiology and Population Health and the Stanford Center for Population Health Sciences. His research focuses on improving the measurement of structural racism in epidemiologic studies, the cardiopulmonary and mental health of Multiracial people in the United States, and the application of methods in social epidemiology to racial health inequities. Dr. Lam-Hine also collaborates with state and local health jurisdictions in California and Hawaii in applied epidemiology and surveillance projects on topics including structural racism, adolescent health, and COVID-19.
-
Marvin Langston
Assistant Professor of Epidemiology and Population Health
BioDr. Marvin Langston is an Assistant Professor of Epidemiology and Population Health. He is a member of the Stanford Cancer Institute and Urologic Cancer Epidemiology Lab. He is an epidemiologist by training who focuses on the fields of benign prostate and pelvic conditions and urological cancers including prostate and kidney cancers.
Prior to Stanford, he served as a Research Scientist in the Division of Research at Kaiser Permanente Northern California. Dr. Langston received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine.
His program of research intends to characterize and measure infectious agents, environmental toxicants, and lifestyle factors; to evaluate the role of these factors in urological cancer etiology and outcomes; and to identify populations at high risk of exposure to these factors. So far he has focused this research to address the following questions: 1) What role do sexually transmitted infections and other systemic infections have in prostate damage and ensuing prostate cancer risk? 2) How can we appropriately model and define early life risk factors for urological cancers? 3) Can we harmonize molecular and clinical aspects of urological condition diagnoses to produce well characterized outcomes for biomarker discovery and etiological investigation? He has primarily addressed these questions using a variety of molecular and clinical epidemiology approaches while developing expertise in the cross-cutting theme of cancer health disparities with particular interests in the cancer care experiences of sexual and gender minorities and racial/ethnic minorities.
Dr. Langston has been studying the impact of exogenous factors on prostate specific antigen (PSA) concentration in young men as a marker of prostate damage and inflammation for over a decade. As early life PSA has been found predictive of future prostate cancer mortality, he has now setout to optimize risk-stratified screening for prostate cancer. This promising approach uses men’s baseline PSA values to inform their risk of future aggressive and/or fatal prostate cancer and determine their frequency of further screening. Under this approach, men with high baseline age-specific total PSA levels receive more frequent screening and men with lower levels receive less frequent screening. Dr. Langston was awarded an R01 from NCI to evaluate this approach using historically collected biospecimen. His funded research trajectory to this point also includes four training awards (2-NCI and 2-NIDDK) and several internal grants. Dr. Langston was selected in the inaugural class of the White House Cancer Moonshot Scholars for his work. -
Jennifer Lee
Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI am a clinical scientist (PhD epidemiology), endocrinologist, and CMO at VAPA Cooperative Studies Program Coordinating Center. My group does pattern and prediction mapping along the life-course of interventions/outcomes and how healthcare system can positively impact health longitudinally. We use novel molecular epi, 'big' data like EHRs using multiple designs/methods/technologies. These interests cut across multiple complex chronic diseases and lifespan.
https://med.stanford.edu/jleelab.html
